Avanos Medical (AVNS) Share-based Compensation Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 5.54% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.09% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 5.29% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 7.15% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 13.40% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 12.36% |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | -2.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.57% |
| Dec 31, 2025 | -33.06% |
| Sep 30, 2025 | -5.14% |
| Jun 30, 2025 | 0.83% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 8.20% |
| Sep 30, 2024 | -9.43% |
| Jun 30, 2024 | 1.82% |
| Mar 31, 2024 | 5.11% |
| Dec 31, 2023 | 7.72% |
| Sep 30, 2023 | 4.68% |
| Jun 30, 2023 | 9.14% |
| Mar 31, 2023 | 16.96% |
| Dec 31, 2022 | 33.01% |
| Sep 30, 2022 | 13.56% |
| Jun 30, 2022 | 30.50% |
| Mar 31, 2022 | -3.28% |
| Dec 31, 2021 | 6.27% |
| Sep 30, 2021 | 13.40% |
| Jun 30, 2021 | 19.68% |
| Mar 31, 2021 | -3.96% |
| Dec 31, 2020 | 65.97% |
| Sep 30, 2020 | 17.42% |
| Jun 30, 2020 | -17.79% |
| Mar 31, 2020 | -17.17% |
| Dec 31, 2019 | -12.06% |
| Sep 30, 2019 | -2.27% |
| Jun 30, 2019 | -31.09% |
| Mar 31, 2019 | 3.39% |
| Sep 30, 2018 | -10.96% |
| Jun 30, 2018 | -26.55% |
| Mar 31, 2018 | -13.46% |
| Dec 31, 2017 | -37.00% |
| Sep 30, 2017 | -11.21% |
| Jun 30, 2017 | 56.83% |
| Mar 31, 2017 | 84.55% |
| Dec 31, 2016 | 24.36% |